Attached files

file filename
EX-10.1 - EX-10.1 - INCYTE CORPa13-14429_1ex10d1.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  May 30, 2013

 

INCYTE CORPORATION

(Exact name of registrant as specified in its charter)

 

Delaware

 

0-27488

 

94-3136539

(State or Other Jurisdiction of

 

(Commission File Number)

 

(I.R.S. Employer

Incorporation)

 

 

 

Identification No.)

 

Experimental Station

 

 

Route 141 & Henry Clay Road

 

 

Building E336

 

 

Wilmington, DE

 

19880

(Address of principal executive offices)

 

(Zip Code)

 

(302) 498-6700

(Registrant’s telephone number,
including area code)

 

N/A

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

Item 3.02                                           Unregistered Sales of Equity Securities.

 

On May 30, 2013 and June 3 and 4, 2013, Incyte Corporation (the “Company”) entered into separately negotiated agreements with certain holders of the Company’s  4.75% Convertible Senior Notes due 2015 (the “Notes”) pursuant to which such holders agreed to exchange $37,461,000 in aggregate principal amount of Notes for the shares of the Company’s common stock, par value $.001 per share (“Common Stock”), into which such Notes were convertible, aggregating 4,269,056 shares, and $2,546,637 in cash.  The Company has completed a portion of the exchanges and expects to complete the remaining exchanges on June 6, 2013.  The issuances of the shares of Common Stock in exchange for the Notes are being made in reliance on the exemption from the registration requirements of the Securities Act of 1933 pursuant to Section 3(a)(9) thereof.

 

Forward-Looking Statements

 

The statement above with respect to the anticipated timing of the completion of the exchanges is a forward-looking statement within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. This forward-looking statement is subject to risks and uncertainties that may cause actual results to differ materially, including the satisfaction of customary closing conditions and logistics involved in the delivery of the securities being exchanged. The Company disclaims any intent or obligation to update this forward-looking statement except to the extent required by law or regulations.

 

Item 5.02                                           Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

At the Annual Meeting of Stockholders of the Company, held on May 30, 2013 (the “Annual Meeting”), the Company’s stockholders approved the Company’s Amended and Restated 2010 Stock Incentive Plan, which included amendments to increase the number of shares available for issuance under the plan by 5,200,000 shares, from 16,553,475 shares to 21,753,475 shares, and make certain additional changes, as described in the Company’s definitive proxy statement for the Annual Meeting.  A copy of the Company’s Amended and Restated 2010 Stock Incentive Plan is attached hereto as Exhibit 10.1 and is incorporated herein by reference.

 

Item 5.07                                           Submission of Matters to a Vote of Security Holders.

 

The following actions were taken at the Annual Meeting:

 

1.                                      The following Directors were elected:

 

 

 

For

 

Withheld

 

Broker Non-Votes

 

 

 

 

 

 

 

Richard U. De Schutter

 

111,613,678

 

1,208,946

 

11,209,990

 

 

 

 

 

 

 

Barry M. Ariko

 

111,656,478

 

1,166,146

 

11,209,990

 

 

 

 

 

 

 

Julian C. Baker

 

111,602,034

 

1,220,590

 

11,209,990

 

 

 

 

 

 

 

Paul A. Brooke

 

111,531,874

 

1,290,750

 

11,209,990

 

 

 

 

 

 

 

Wendy L. Dixon

 

112,094,498

 

728,126

 

11,209,990

 

 

 

 

 

 

 

Paul A. Friedman

 

112,006,102

 

816,522

 

11,209,990

 

 

 

 

 

 

 

Roy A. Whitfield

 

78,542,641

 

34,279,983

 

11,209,990

 

2.                                      The Company’s Amended and Restated 2010 Stock Incentive Plan was approved.

 

For

 

Against

 

Abstain

 

Broker Non-Votes

79,170,761

 

33,345,530

 

306,333

 

11,209,990

 

2



 

3.                                      The compensation of the Company’s named executive officers was approved, on a non-binding advisory basis.

 

For

 

Against

 

Abstain

 

Broker Non-Votes

95,005,898

 

17,400,369

 

416,357

 

11,209,990

 

4.                                      The appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the 2013 fiscal year was ratified.

 

For

 

Against

 

Abstain

121,921,585

 

2,039,827

 

71,202

 

Item 9.01                                           Financial Statements and Exhibits.

 

(d)                                 Exhibits

 

10.1                        Incyte Corporation Amended and Restated 2010 Stock Incentive Plan.

 

3



 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated:  June 5, 2013

 

 

INCYTE CORPORATION

 

 

 

 

 

By:

/s/ Eric H Siegel

 

 

Eric H. Siegel

 

 

Executive Vice President and General Counsel

 

4